The following audio is from a conference call that will begin on November 12, 2013 at 08:00 AM ET. The audio will stream live while the call is active, and can be replayed upon its completion.If you would like to view a transcript of this call, please click here.
Sarepta Therapeutics (SRPT): Q3 EPS of -$0.63 in-line. Revenue of $4.2M misses by $0.37M. (PR)